Yuko Ozaki
Hiroshima University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yuko Ozaki.
Cancer Cell | 2013
Akiko Nagamachi; Hirotaka Matsui; Hiroya Asou; Yuko Ozaki; Daisuke Aki; Akinori Kanai; Keiyo Takubo; Toshio Suda; Takuro Nakamura; Linda Wolff; Hiroaki Honda; Toshiya Inaba
Monosomy 7 and interstitial deletion of 7q (-7/7q-) are well-recognized nonrandom chromosomal abnormalities frequently found among patients with myelodysplastic syndromes (MDSs) and myeloid leukemias. We previously identified candidate myeloid tumor suppressor genes (SAMD9, SAMD9-like = SAMD9L, and Miki) in the 7q21.3 subband. We established SAMD9L-deficient mice and found that SAMD9L(+/-) mice as well as SAMD9L(-/-) mice develop myeloid diseases resembling human diseases associated with -7/7q-. SAMD9L-deficient hematopoietic stem cells showed enhanced colony formation potential and in vivo reconstitution ability. SAMD9L localizes in early endosomes. SAMD9L-deficient cells showed delays in homotypic endosome fusion, resulting in persistence of ligand-bound cytokine receptors. These findings suggest that haploinsufficiency of SAMD9L and/or SAMD9 gene(s) contributes to myeloid transformation.
Molecular Cell | 2012
Yuko Ozaki; Hirotaka Matsui; Hiroya Asou; Akiko Nagamachi; Daisuke Aki; Hiroaki Honda; Shin’ichiro Yasunaga; Yoshihiro Takihara; Tadashi Yamamoto; Shunsuke Izumi; Miho Ohsugi; Toshiya Inaba
During prometaphase, dense microtubule nucleation sites at centrosomes form robust spindles that align chromosomes promptly. Failure of centrosome maturation leaves chromosomes scattered, as seen routinely in cancer cells, including myelodysplastic syndrome (MDS). We previously reported that the Miki (LOC253012) gene is frequently deleted in MDS patients, and that low levels of Miki are associated with abnormal mitosis. Here we demonstrate that Miki localizes to the Golgi apparatus and is poly(ADP-ribosyl)ated by tankyrase-1 during late G2 and prophase. PARsylated Miki then translocates to mitotic centrosomes and anchors CG-NAP, a large scaffold protein of the γ-tubulin ring complex. Due to impairment of microtubule aster formation, cells in which tankyrase-1, Miki, or CG-NAP expression is downregulated all show prometaphase disturbances, including scattered and lagging chromosomes. Our data suggest that PARsylation of Miki by tankyrase-1 is a key initial event promoting prometaphase.
Journal of Biological Chemistry | 2011
Yuko Ozaki; Hirotaka Matsui; Akiko Nagamachi; Hiroya Asou; Daisuke Aki; Toshiya Inaba
The dynactin complex is required for activation of the dynein motor complex, which plays a critical role in various cell functions including mitosis. During metaphase, the dynein-dynactin complex removes spindle checkpoint proteins from kinetochores to facilitate the transition to anaphase. Three components (p150Glued, dynamitin, and p24) compose a key portion of the dynactin complex, termed the projecting arm. To investigate the roles of the dynactin complex in mitosis, we used RNA interference to down-regulate p24 and p150Glued in human cells. In response to p24 down-regulation, we observed cells with delayed metaphase in which chromosomes frequently align abnormally to resemble a “figure eight,” resulting in cell death. We attribute the figure eight chromosome alignment to impaired metaphasic centrosomes that lack spindle tension. Like p24, RNA interference of p150Glued also induces prometaphase and metaphase delays; however, most of these cells eventually enter anaphase and complete mitosis. Our findings suggest that although both p24 and p150Glued components of the dynactin complex contribute to mitotic progression, p24 also appears to play a role in metaphase centrosome integrity, helping to ensure the transition to anaphase.
Biochemical and Biophysical Research Communications | 2009
Hiroya Asou; Hirotaka Matsui; Yuko Ozaki; Akiko Nagamachi; Megumi Nakamura; Daisuke Aki; Toshiya Inaba
Blood | 2015
Akiko Nagamachi; Yuko Ozaki; Hirotaka Matsui; Akinori Kanai; Toshiya Inaba
Experimental Hematology | 2013
Hirotaka Matsui; Akiko Nagamachi; Yuko Ozaki; Akinori Kanai; Hiroaki Honda; Toshiya Inaba
Blood | 2012
Hirotaka Matsui; Yuko Ozaki; Akiko Nagamachi; Toshiya Inaba
Blood | 2011
Hirotaka Matsui; Akiko Nagamachi; Yuko Ozaki; Hiroya Asou; Hiroaki Honda; Toshiya Inaba
Blood | 2010
Hirotaka Matsui; Akiko Nagamachi; Yuko Ozaki; Hiroya Asou; Hiroaki Honda; Toshiya Inaba
Blood | 2009
Hirotaka Matsui; Akiko Nagamachi; Yuko Ozaki; Daisuke Aki; Hiroya Asou; Hiroaki Honda; Toshiya Inaba